233 related articles for article (PubMed ID: 24089513)
1. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass.
Shah M; Law JH; Micheletto F; Sathananthan M; Dalla Man C; Cobelli C; Rizza RA; Camilleri M; Zinsmeister AR; Vella A
Diabetes; 2014 Feb; 63(2):483-93. PubMed ID: 24089513
[TBL] [Abstract][Full Text] [Related]
2. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
[TBL] [Abstract][Full Text] [Related]
3. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
[TBL] [Abstract][Full Text] [Related]
4. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Jonsson I; Bojsen-Møller KN; Kristiansen VB; Veedfald S; Wewer Albrechtsen NJ; Clausen TR; Kuhre RE; Rehfeld JF; Holst JJ; Madsbad S; Svane MS
Front Endocrinol (Lausanne); 2021; 12():681116. PubMed ID: 34084153
[TBL] [Abstract][Full Text] [Related]
5. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
7. Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.
Jørgensen NB; Dirksen C; Bojsen-Møller KN; Jacobsen SH; Worm D; Hansen DL; Kristiansen VB; Naver L; Madsbad S; Holst JJ
Diabetes; 2013 Sep; 62(9):3044-52. PubMed ID: 23649520
[TBL] [Abstract][Full Text] [Related]
8. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
Korner J; Bessler M; Inabnet W; Taveras C; Holst JJ
Surg Obes Relat Dis; 2007; 3(6):597-601. PubMed ID: 17936091
[TBL] [Abstract][Full Text] [Related]
9. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
11. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.
Salehi M; Gastaldelli A; D'Alessio DA
Gastroenterology; 2014 Mar; 146(3):669-680.e2. PubMed ID: 24315990
[TBL] [Abstract][Full Text] [Related]
12. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
13. Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.
Svane MS; Bojsen-Møller KN; Martinussen C; Dirksen C; Madsen JL; Reitelseder S; Holm L; Rehfeld JF; Kristiansen VB; van Hall G; Holst JJ; Madsbad S
Gastroenterology; 2019 May; 156(6):1627-1641.e1. PubMed ID: 30742833
[TBL] [Abstract][Full Text] [Related]
14. Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects.
Sathananthan M; Farrugia LP; Miles JM; Piccinini F; Dalla Man C; Zinsmeister AR; Cobelli C; Rizza RA; Vella A
Diabetes; 2013 Aug; 62(8):2752-6. PubMed ID: 23545708
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification.
Vetter ML; Wadden TA; Teff KL; Khan ZF; Carvajal R; Ritter S; Moore RH; Chittams JL; Iagnocco A; Murayama K; Korus G; Williams NN; Rickels MR
Diabetes; 2015 Feb; 64(2):434-46. PubMed ID: 25204975
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
18. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies.
Hindsø M; Svane MS; Hedbäck N; Holst JJ; Madsbad S; Bojsen-Møller KN
Surg Obes Relat Dis; 2021 Jul; 17(7):1383-1391. PubMed ID: 33771461
[TBL] [Abstract][Full Text] [Related]
19. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
